05/09/2024
5:58 AM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
3:23 PM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024
5:28 AM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
7:30 AM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
5:30 AM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
3:30 PM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
8:20 AM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
03/21/2024
4:08 PM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/21/2024
6:43 AM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
4:19 PM | DiBiase Mary (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:19 PM | Mostafa Adam S. (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:20 PM | Ragan Paula (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:20 PM | Taveras Arthur (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
3:16 PM | Taveras Arthur (Reporting)
X4 Pharmaceuticals, Inc (Subject)
X4 Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
4:52 PM | Arbet-Engels Christophe (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4/A | |
02/14/2024
6:36 PM | ORBIMED ADVISORS LLC (Filed by)
X4 Pharmaceuticals, Inc (Subject)
X4 Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/14/2024
3:44 PM | ACORN BIOVENTURES, L.P. (Filed by)
X4 Pharmaceuticals, Inc (Subject)
X4 Pharmaceuticals (Subject)
| Form SC 13G | |
02/13/2024
5:55 PM | Bain Capital Life Sciences Fund, L.P. (Filed by)
X4 Pharmaceuticals, Inc (Subject)
X4 Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/12/2024
4:23 PM | Taveras Arthur (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
4:23 PM | DiBiase Mary (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
3:27 PM | Mostafa Adam S. (Reporting)
X4 Pharmaceuticals, Inc (Subject)
X4 Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
3:28 PM | Taveras Arthur (Reporting)
X4 Pharmaceuticals, Inc (Subject)
X4 Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/07/2024
4:09 PM | BlackRock Inc. (Filed by)
X4 Pharmaceuticals, Inc (Subject)
X4 Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/31/2024
1:08 PM | BlackRock Inc. (Filed by)
X4 Pharmaceuticals, Inc (Subject)
X4 Pharmaceuticals (Subject)
| Form SC 13G | |
01/08/2024
9:26 AM | Empery Asset Management, LP (Filed by)
X4 Pharmaceuticals, Inc (Subject)
X4 Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/27/2023
4:20 PM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2023
3:10 PM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
4:11 PM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/09/2023
7:07 AM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/03/2023
4:26 PM | Ragan Paula (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
3:39 PM | Taveras Arthur (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
3:39 PM | Baldry Mark (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
3:40 PM | DiBiase Mary (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
3:42 PM | Mostafa Adam S. (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2023
7:17 AM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2023
3:04 PM | DiBiase Mary (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2023
3:15 PM | Arbet-Engels Christophe (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
11:15 PM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form EFFECT | |
08/16/2023
3:16 PM | Arbet-Engels Christophe (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/11/2023
6:26 PM | Stewart Murray (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2023
5:41 AM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad) Are you monitoring 13,217 cryptocurrencies everyday?
If not, you could miss the ONE that can make you wealthy beyond your wildest dreams.
You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. |
08/03/2023
3:41 PM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2023
2:42 PM | DiBiase Mary (Reporting)
X4 Pharmaceuticals, Inc (Subject)
X4 Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/30/2023
2:29 PM | Mostafa Adam S. (Reporting)
X4 Pharmaceuticals, Inc (Subject)
X4 Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2023
3:15 PM | DiBiase Mary (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
3:11 PM | Ragan Paula (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
3:13 PM | Mostafa Adam S. (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
2:44 PM | DiBiase Mary (Reporting)
X4 Pharmaceuticals, Inc (Subject)
X4 Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/23/2023
2:26 PM | Mostafa Adam S. (Reporting)
X4 Pharmaceuticals, Inc (Subject)
X4 Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/23/2023
2:29 PM | Ragan Paula (Reporting)
X4 Pharmaceuticals, Inc (Subject)
X4 Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2023
11:15 PM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form EFFECT | |
06/16/2023
3:24 PM | DiBiase Mary (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:35 PM | Ragan Paula (Reporting)
X4 Pharmaceuticals, Inc (Subject)
X4 Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/15/2023
3:38 PM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/15/2023
2:52 PM | Mostafa Adam S. (Reporting)
X4 Pharmaceuticals, Inc (Subject)
X4 Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2023
3:59 PM | WYZGA MICHAEL S (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
4:03 PM | MCGIRR DAVID W J (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
4:05 PM | Bridger Gary (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
4:10 PM | Aliski William (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
3:51 PM | Lawton Alison Frances (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
3:57 PM | de Craecker Francoise (Reporting)
X4 Pharmaceuticals, Inc (Issuer)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2023
3:16 PM | X4 Pharmaceuticals, Inc (Filer)
X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/26/2023
2:03 PM | Growth Equity Opportunities 18 VGE, LLC (Filed by)
X4 Pharmaceuticals, Inc (Subject)
X4 Pharmaceuticals (Subject)
| Form SC 13D/A | |
